RG
ALXN
Redmile Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,162,200
| Closed | -$114M | – | 83 |
|
|
2019
Q3 | $114M | Buy |
+1,162,200
| New | +$114M | 3.81% | 8 |
|
|
2018
Q3 | – | Sell |
-489,300
| Closed | -$60.7M | – | 100 |
|
|
2018
Q2 | $60.7M | Buy |
489,300
+84,500
| +21% | +$10.5M | 2.06% | 16 |
|
|
2018
Q1 | $45.1M | Buy |
+404,800
| New | +$45.1M | 1.74% | 23 |
|
|
2016
Q4 | – | Sell |
-45,410
| Closed | -$5.57M | – | 61 |
|
|
2016
Q3 | $5.57M | Sell |
45,410
-156,990
| -78% | -$19.2M | 0.44% | 36 |
|
|
2016
Q2 | $23.6M | Buy |
+202,400
| New | +$23.6M | 2.26% | 20 |
|
|
2015
Q2 | – | Sell |
-1,390
| Closed | -$241K | – | 65 |
|
|
2015
Q1 | $241K | Hold |
1,390
| – | – | 0.02% | 53 |
|
|
2014
Q4 | $257K | Buy |
+1,390
| New | +$257K | 0.03% | 53 |
|
|
2013
Q3 | – | Sell |
-38,700
| Closed | -$3.57M | – | 63 |
|
|
2013
Q2 | $3.57M | Buy |
+38,700
| New | +$3.57M | 0.63% | 37 |
|